Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • ?-THALASSEMIA DISTRIBUTION IN THE OLD WORLD: A HISTORICAL STANDPOINT OF AN ANCIENT DISEASE

    Vincenzo De Sanctis
    e2017018
    2017-02-20
    https://doi.org/10.4084/mjhid.2017.018
    11166
    PDF: 4364
    HTML: 4369
  • NEW STRATEGIES FOR STEM CELL MOBILIZATION

    Roberto Lemoli
    e2012066
    2012-10-03
    https://doi.org/10.4084/mjhid.2012.066
    2447
    PDF: 872
    HTML: 2463
  • Very late onset Post-Transplantation Lymphoproliferative Disorder (PTLD) after haematopoietic stem cell transplant (HCT) – A Clinical Case

    Sharon Lionel, Liron Barnea Slonim, Guy Hannah, Victoria Potter, Daniele Avenoso
    e2024048
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.048
    1030
    PDF: 993
    HTML: 156
  • THE GROWING ROLE OF THE BH3 MIMETIC DRUG VENETOCLAX IN THE THERAPY OF ACUTE MYELOID LEUKEMIA

    Elvira Pelosi, Dr. Germana Castelli, Ugo Testa
    e2022080
    2022-10-29
    https://doi.org/10.4084/MJHID.2022.080
    1526
    PDF: 1171
    HTML: 287
  • The risk of SARS-CoV-2 reinfection in Duhok city, Kurdistan Region of Iraq

    Nawfal R Hussein
    Page e2021035
    2021-04-29
    https://doi.org/10.4084/MJHID.2021.035
    1222
    PDF: 550
    HTML: 419
  • THE PROGNOSTIC SIGNIFICANCE OF TET2 SINGLE NUCLEOTIDE POLYMORPHISM IN EGYPTIAN CHRONIC MYELOID LEUKEMIA THE PROGNOSTIC SIGNIFICANCE OF TET2 SINGLE NUCLEOTIDE POLYMORPHISM IN EGYPTIAN CHRONIC MYELOID LEUKEMIA

    Enas A Dammag, Nahla A.M. Hamed, Professor, Nabil A El Halawani, Professor, Heba S Kassem, Professor, Mona W Ayad, Professor
    e2020004
    2020-01-01
    https://doi.org/10.4084/mjhid.2020.004
    2068
    PDF: 992
    HTML: 318
  • 30 YEARS RETROSPECTIVE REVIEW OF TUBERCULOSIS CASES IN A TUBERCULOSIS DISPENSARY IN BURSA/NILUFER, TURKEY (1985-2014)

    Kayıhan PALA, Harika GERÇEK, Tuncay AYDIN TAŞ, Rukiye ÇAKIR, Sedef ÖZGÜÇ, Timur YILDIZ
    e2016059
    2016-11-01
    https://doi.org/10.4084/mjhid.2016.059
    3314
    PDF: 830
    HTML: 1755
  • SHORT TERM ADVANTAGES OF A PUBLIC-PRIVATE PARTNERSHIP FOR TUBERCULOSIS IN GUINEA BISSAU: REDUCTION OF MORTALITY AND INCREASED DIAGNOSTIC CAPACITY

    Fina Vieira, Mamadu Saliu Sanha, Fabio Riccardi, Raffaella Colombatti
    e2014049
    2014-06-29
    https://doi.org/10.4084/mjhid.2014.049
    1428
    PDF: 917
    HTML: 1283
    Untitled: 180
  • Epstein-Barr Virus (EBV)-associated Haemophagocytic Syndrome

    Lorenza Torti, Luigi Maria Larocca, Giuseppina Massini, Luciana Teofili
    e2012008
    2012-01-25
    https://doi.org/10.4084/mjhid.2012.008
    1866
    PDF: 847
    HTML: 1592
  • PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID

    Francesco Rodeghiero
    e2021032
    2021-04-29
    https://doi.org/10.4084/MJHID.2021.032
    2621
    PDF: 944
    HTML: 551
  • Calreticulin mutation survey by high resolution melting method associated with unique presentations in essential thrombocythemic patients CALR mutation survey by HRM in ET patients

    Yi-Chang Liu, Ching-Ping Lee, Tsung-Jang Yeh, Yuh-Ching Gau, Chieh-Yu Hsieh, Ya-Lun Ke, Jeng-Shiun Du, Ming-Hui Lin, Hui-Ching Wang, Shih-Hao Tang, Shih-Feng Cho, Jui-Feng Hsu, Samuel Yien Hsiao, Chin-Mu Hsu, Hui-Hua Hsiao
    e2020022
    2020-04-27
    https://doi.org/10.4084/mjhid.2020.022
    1277
    PDF: 740
    HTML: 437
  • FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.

    Andrea Gallamini, Anna Borra
    e2017029
    2017-04-15
    https://doi.org/10.4084/mjhid.2017.029
    3331
    PDF: 1250
    HTML: 2209
  • Lung Clear “Sugar” Cell Tumor and Jak V617f Positive Essential Thrombocythemia: A simple Co?nc?dence?

    Volkan Yazak, Gokhan Sargin, Irfan Yavasoglu, Gurhan Kadikoylu, Canten Tataroglu, Gokay Bozkurt, Zahit Bolaman
    e2013021
    2013-04-10
    https://doi.org/10.4084/mjhid.2013.021
    1287
    PDF: 718
    HTML: 2631
  • BIOLOGY OF HUMAN MALARIA PLASMODIA INCLUDING PLASMODIUM KNOWLESI

    Spinello Antinori, Laura Galimberti, Laura Milazzo, Mario Corbellino
    e2012013
    2012-03-09
    https://doi.org/10.4084/mjhid.2012.013
    5359
    PDF: 2770
    HTML: 30227
    Antinori Tables 1,2,3: 357
301 - 314 of 314 items << < 2 3 4 5 6 7 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.